Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer

49Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The liver is a lymphoid organ with unique immunological properties, particularly, its predominant innate immune system. The balance between immune tolerance and immune activity is critical to liver physiological functions and is responsible for the sensitivity of this organ to numerous diseases, including hepatotropic virus infection, alcoholic liver disease, nonalcoholic fatty liver disease, autoimmune liver disease, and liver cancer, which are major health problems globally. In the past decade, with the discovery of liver-resident natural killer cells, the importance of innate lymphocytes with tissue residency has gradually become the focus of research. In this review, we address the current knowledge regarding hepatic innate lymphocytes with unique characteristics, including NK cells, ILC1/2/3s, NKT cells, γδ T cells, and MAIT cells, and their potential roles in liver homeostasis maintenance and the progression of liver diseases and cancer. A better understanding of the immunopathogenesis of hepatic innate lymphocytes will be helpful for proposing effective treatments for liver diseases and cancer.

Cite

CITATION STYLE

APA

Chen, Y., & Tian, Z. (2021, January 1). Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer. Cellular and Molecular Immunology. Springer Nature. https://doi.org/10.1038/s41423-020-00561-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free